|
National Stock Number(NSN): 6505-01-363-0019 (6505013630019, 013630019)
| NIIN: |
01-363-0019 |
Item Name: |
DILTIAZEM EXTENDED-RELEASE CAPSULES |
INC: |
47910
|
| FSC: |
6505
|
Assignment Date: |
Aug-19-1992 |
CRIT: |
X |
IIG: |
47910 |
| ISC: |
5 |
Date Standardized: |
Aug-19-1992 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
A |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
3004.90.9220 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
CARDIZEM CD |
24268
|
SANOFI US SERVICES INC. |
H |
5 |
1 |
6 |
54 |
|
|
|
|
|
|
|
L93-363 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00088-1796-90 |
24268
|
SANOFI US SERVICES INC. |
H |
3 |
9 |
6 |
54 |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
Y |
|
M |
U |
1 |
A |
$6,510.57 |
DR |
|
C2201X- |
Mar-01-2003 |
H |
| DF |
|
Y |
|
|
|
|
F |
$0.00 |
DR |
|
------- |
Jan-01-2003 |
H |
| DN |
S9M |
Y |
|
M |
U |
1 |
N |
$6,510.57 |
DR |
|
9L----- |
Dec-01-2002 |
H |
| DS |
S9M |
H |
|
M |
U |
1 |
D |
$6,510.57 |
DR |
|
------- |
Oct-01-2002 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 5000EA |
000 |
|
|
|
| DA |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 5000EA |
000 |
|
|
|
| DF |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 5000EA |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 5000EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
180.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT |
| AKJC |
CAPSULE TYPE |
SOFT |
| CQCT |
PRIMARY CONTAINER TYPE |
DRUM |
| CQLS |
CAPSULE CONTENT FORM |
PELLET |
| CSGS |
ADMINISTRATION |
ORAL |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
DILTIAZEM EXTENDED-RELEASE CAPSULES USP 180MG 5000S DRUM |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
5000.000 |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| THPE |
THERAPEUTIC EQUIVALENT |
MARION MERRELL DOW |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|